GNRH1 and Alzheimer disease: Reduced levels of GnRH may contribute to the development of AD pathology, as the treatment with GnRH lowered hippocampal plaque load, reduced the Aβ concentration in brains of C57BL/6 mice, and prevented AD-related cognitive dysfunctions [57,58].